The NIMML Institute

5.6K posts

The NIMML Institute banner
The NIMML Institute

The NIMML Institute

@NIMMLab

Tackling unsolved challenges in complex human #diseases with unmet clinical needs using #PrecisionMedicine #AI #Immunometabolism

Blacksburg, VA Katılım Aralık 2013
3.8K Takip Edilen3.1K Takipçiler
The NIMML Institute
The NIMML Institute@NIMMLab·
At #IMMUNOLOGY2026 we shared new data on omilancor, an oral, once-daily gut-restricted LANCL2 medicine—showing strong efficacy signals in IBD, recurrent C. difficile infection model and concomitant CDI and IBD. Read the article below.
BioTherapeutics Inc.@BioTherap

At #IMMUNOLOGY2026 we shared new data on omilancor, an oral, once-daily gut-restricted LANCL2 medicine—showing strong efficacy signals in IBD, recurrent C. difficile infection model and concomitant CDI and IBD. Read the article: nimmunebio.com/nimmune-biopha…

English
0
0
0
101
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
Dr. Josep Bassaganya‑Riera is launching a clinical program advancing NIM‑1324 a next‑gen oral, once-daily LANCL2 therapeutic for IBD. NIM‑1324 targets both gut and extraintestinal disease through a systemic approach. Results will be presented at #DDW2026. businesswire.com/news/home/2026…
NImmune Biopharma tweet media
English
0
1
1
60
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
Dr. Josep Bassaganya-Riera, our Founder & CEO, was featured on the Biotech Blueprint podcast, delving into the scientific underpinnings of how NImmune’s lead candidates outperform current IBD drugs in efficacy and safety. Listen here: open.spotify.com/show/6bn77qe68…
NImmune Biopharma tweet media
English
0
1
0
44
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
Listen to Dr. Josep Bassaganya-Riera, Founder & CEO of NImmune, on @BiotechnologyPa’s Biotech Insiders podcast as he shares how AI is transforming drug development and why high-precision immunology is key to disrupting the I&I disease treatment paradigm. podcasts.apple.com/us/podcast/bio…
NImmune Biopharma tweet media
English
0
1
1
41
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
ICYMI: Eli Lilly and Nvidia recently announced a new partnership to leverage AI capabilities for drug discovery & development. At NImmune, we've successfully demonstrated how advanced AI models can greatly accelerate therapeutic discovery & development. nimmunebio.com/the-nimml-inst…
NImmune Biopharma tweet media
English
0
1
1
39
The NIMML Institute
The NIMML Institute@NIMMLab·
We are excited to contribute to the 3rd edition of “Goals in Nutrition Science” (2025–2030), a forthcoming initiative from @FrontNutrition sharing global perspectives on the future of the field, incl. a section on immunometabolism from our founder Josep Bassaganya-Riera. (1/2)
The NIMML Institute tweet media
English
2
1
1
31
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
Listen to our Founder & CEO, Dr. Josep Bassaganya-Riera, on the @BioWorld Insider podcast, where he discusses how NImmune is leveraging the TITAN-X AI platform to advance precision medicine in inflammatory and autoimmune diseases. Listen here: bioworld.com/media/podcasts…
NImmune Biopharma tweet media
English
0
2
3
186
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
Today on #WorldIBDDay, we stand with the global IBD community in the fight against Crohn’s disease and ulcerative colitis. At NImmune, our team is advancing omilancor, a first-in-class oral therapeutic targeting LANCL2, now in Phase 3.
NImmune Biopharma tweet media
English
0
2
3
162
The NIMML Institute
The NIMML Institute@NIMMLab·
New data presented at #DDW2025 shows LANCL2 activation via omilancor outperforms anti-TL1A in IBD. Backed by our TITAN-X A.I. platform, results show superior efficacy, unmatched safety, and reversal of Treg/mitochondrial dysfunction in UC. Read more: businesswire.com/news/home/2025…
The NIMML Institute tweet media
English
0
1
4
111
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
Thrilled to share that our Founder & CEO, Dr. Josep Bassaganya-Riera, was featured on @LaunchBio’s NextGen VC podcast to discuss his journey building Landos Biopharma from new scientific findings to a $600M market cap company. Listen here: launchbio.org/nextgen-vc-pod…
NImmune Biopharma tweet media
English
0
2
3
62
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
Check out our Founder & CEO, Dr. Josep Bassaganya-Riera, on the Life Science & Biotech CEO Stories podcast as he shares his success story and how he's leading the charge in applying A.I. to biotech innovation. Listen here: biotechinsights.net/post/he-s-sett…
NImmune Biopharma tweet media
English
0
2
2
51
The NIMML Institute
The NIMML Institute@NIMMLab·
New editorial from Dr. Bassaganya-Riera introducing recent research on the use of computational modeling to study T-cell response. The power of advanced computational modeling of T-cell responses using the TITAN-X A.I. platform has accelerated target discovery & drug development.
NImmune Biopharma@NImmuneBio

Our Founder and CEO, Dr. Bassaganya-Riera, recently edited a collection of articles for @FrontiersIn Immunology on new computational modeling methods to study alloimmune T-cell responses. Read the full editorial here: frontiersin.org/journals/immun… #BioPharma

English
0
0
2
71
The NIMML Institute
The NIMML Institute@NIMMLab·
We are pleased to announce that new data from two IBD studies will be presented at @DDWMeeting. The studies focus on the best-in-class efficacy and safety, novel mechanism and combination therapies of omilancor & TL1A. Read more: #DDW2025" target="_blank" rel="nofollow noopener">nimml.org/news/detail/ni…
The NIMML Institute tweet media
English
0
1
2
77
The NIMML Institute
The NIMML Institute@NIMMLab·
Our paper on Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus, was accepted to the #CTSJournal! Findings validated NIM-1324 as a well-tolerated treatment for SLE. Read it in @ASCPTjournals: #ASCPTJournalFamily" target="_blank" rel="nofollow noopener">nimml.org/news/detail/th…
The NIMML Institute tweet media
English
0
2
3
174
The NIMML Institute retweetledi
NImmune Biopharma
NImmune Biopharma@NImmuneBio·
We are pleased to share that NImmune will be attending #JPM2025 in San Francisco from January 13–16! We look forward to engaging in impactful conversations, connecting with industry leaders, and building our network to start 2025 on a strong note.
NImmune Biopharma tweet media
English
0
2
2
83

Keşfet

@NImmuneBio @BiotechnologyPa @FrontNutrition @BioWorld @LaunchBio @AnnualReviews @DDWMeeting @ASCPTjournals